Cargando…
Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above
BACKGROUND: There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help ide...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256211/ https://www.ncbi.nlm.nih.gov/pubmed/34225657 http://dx.doi.org/10.1186/s12879-021-06251-z |
_version_ | 1783718056024866816 |
---|---|
author | Syed, Mohamed Ahmed Al Nuaimi, Ahmed Sameer A/Qotba, Hamda Abdulla Nasrallah, Gheyath K. Althani, Asmaa A. Yassine, Hadi M. Zainel, Abduljaleel Abdullatif Khudadad, Hanan Marji, Tamara Veettil, Shajitha Thekke Al-Jighefee, Hadeel T. Younes, Salma Shurrab, Farah Al-Sadeq, Duaa W. AlFehaidi, Al Anoud Saleh Yfakhroo, Ameena Ibrahim AlMesaifri, Meshal Abdulla Al Mujalli, Hanan Al Abdulla, Samya Ahmad Al Kuwari, Mohamed Ghaith Azad, Faruk Mohammed Al Malki, Badria Ali Mohamed Abdulmalik, Mariam Ali |
author_facet | Syed, Mohamed Ahmed Al Nuaimi, Ahmed Sameer A/Qotba, Hamda Abdulla Nasrallah, Gheyath K. Althani, Asmaa A. Yassine, Hadi M. Zainel, Abduljaleel Abdullatif Khudadad, Hanan Marji, Tamara Veettil, Shajitha Thekke Al-Jighefee, Hadeel T. Younes, Salma Shurrab, Farah Al-Sadeq, Duaa W. AlFehaidi, Al Anoud Saleh Yfakhroo, Ameena Ibrahim AlMesaifri, Meshal Abdulla Al Mujalli, Hanan Al Abdulla, Samya Ahmad Al Kuwari, Mohamed Ghaith Azad, Faruk Mohammed Al Malki, Badria Ali Mohamed Abdulmalik, Mariam Ali |
author_sort | Syed, Mohamed Ahmed |
collection | PubMed |
description | BACKGROUND: There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design and reports findings of a population based epidemiological study undertaken to characterise SARS-CoV2 in Qatar using limited resources in a timely manner. METHODS: Asymptomatic individuals ≥10 years registered with Qatar’s publicly funded primary health provider were eligible. A stratified random sampling technique was utilized to identify the study sample. Participants were invited to an appointment where they completed a questionnaire and provided samples for polymerase chain reaction and Immunoglobulin M and G immunoassay tests. Data collected were analyzed to calculate point and period prevalence by sociodemographic, lifestyle and clinical characteristics. RESULTS: Of 18,918 individuals invited for the study, 2084 participated (response rate 10.8%). The overall point prevalence and period prevalence were estimated to be 1.6% (95% CI 1.1–2.2) and 14.6% (95% CI 13.1–16.2) respectively. Period prevalence of SARS-CoV2 infection was not considerably different across age groups (9.7–19.8%). It was higher in males compared to females (16.2 and 12.7% respectively). A significant variation was observed by nationality (7.1 to 22.2%) and municipalities (6.9–35.3%). CONCLUSIONS: The study provides an example of a methodologically robust approach that can be undertaken in a timely manner with limited resources. It reports much-needed epidemiological data about the spread of SARS-CoV2. Given the low prevalence rates, majority of the population in Qatar remains susceptible. Enhanced surveillance must continue to be in place, particularly due to the large number of asymptomatic cases observed. Robust contact tracing and social distancing measures are key to prevent future outbreaks. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06251-z. |
format | Online Article Text |
id | pubmed-8256211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82562112021-07-06 Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above Syed, Mohamed Ahmed Al Nuaimi, Ahmed Sameer A/Qotba, Hamda Abdulla Nasrallah, Gheyath K. Althani, Asmaa A. Yassine, Hadi M. Zainel, Abduljaleel Abdullatif Khudadad, Hanan Marji, Tamara Veettil, Shajitha Thekke Al-Jighefee, Hadeel T. Younes, Salma Shurrab, Farah Al-Sadeq, Duaa W. AlFehaidi, Al Anoud Saleh Yfakhroo, Ameena Ibrahim AlMesaifri, Meshal Abdulla Al Mujalli, Hanan Al Abdulla, Samya Ahmad Al Kuwari, Mohamed Ghaith Azad, Faruk Mohammed Al Malki, Badria Ali Mohamed Abdulmalik, Mariam Ali BMC Infect Dis Research Article BACKGROUND: There is an urgent need to elucidate the epidemiology of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and characterize its potential impact. Investing in characterising the SARS-CoV2 will help plan and improve the response to the pandemic. Furthermore, it will help identify the most efficient ways of managing the pandemic, avoiding public health policies and interventions that may be unduly restrictive of normal activity or unnecessarily costly. This paper describes the design and reports findings of a population based epidemiological study undertaken to characterise SARS-CoV2 in Qatar using limited resources in a timely manner. METHODS: Asymptomatic individuals ≥10 years registered with Qatar’s publicly funded primary health provider were eligible. A stratified random sampling technique was utilized to identify the study sample. Participants were invited to an appointment where they completed a questionnaire and provided samples for polymerase chain reaction and Immunoglobulin M and G immunoassay tests. Data collected were analyzed to calculate point and period prevalence by sociodemographic, lifestyle and clinical characteristics. RESULTS: Of 18,918 individuals invited for the study, 2084 participated (response rate 10.8%). The overall point prevalence and period prevalence were estimated to be 1.6% (95% CI 1.1–2.2) and 14.6% (95% CI 13.1–16.2) respectively. Period prevalence of SARS-CoV2 infection was not considerably different across age groups (9.7–19.8%). It was higher in males compared to females (16.2 and 12.7% respectively). A significant variation was observed by nationality (7.1 to 22.2%) and municipalities (6.9–35.3%). CONCLUSIONS: The study provides an example of a methodologically robust approach that can be undertaken in a timely manner with limited resources. It reports much-needed epidemiological data about the spread of SARS-CoV2. Given the low prevalence rates, majority of the population in Qatar remains susceptible. Enhanced surveillance must continue to be in place, particularly due to the large number of asymptomatic cases observed. Robust contact tracing and social distancing measures are key to prevent future outbreaks. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06251-z. BioMed Central 2021-07-05 /pmc/articles/PMC8256211/ /pubmed/34225657 http://dx.doi.org/10.1186/s12879-021-06251-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Syed, Mohamed Ahmed Al Nuaimi, Ahmed Sameer A/Qotba, Hamda Abdulla Nasrallah, Gheyath K. Althani, Asmaa A. Yassine, Hadi M. Zainel, Abduljaleel Abdullatif Khudadad, Hanan Marji, Tamara Veettil, Shajitha Thekke Al-Jighefee, Hadeel T. Younes, Salma Shurrab, Farah Al-Sadeq, Duaa W. AlFehaidi, Al Anoud Saleh Yfakhroo, Ameena Ibrahim AlMesaifri, Meshal Abdulla Al Mujalli, Hanan Al Abdulla, Samya Ahmad Al Kuwari, Mohamed Ghaith Azad, Faruk Mohammed Al Malki, Badria Ali Mohamed Abdulmalik, Mariam Ali Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above |
title | Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above |
title_full | Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above |
title_fullStr | Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above |
title_full_unstemmed | Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above |
title_short | Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above |
title_sort | epidemiology of sars-cov2 in qatar’s primary care population aged 10 years and above |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256211/ https://www.ncbi.nlm.nih.gov/pubmed/34225657 http://dx.doi.org/10.1186/s12879-021-06251-z |
work_keys_str_mv | AT syedmohamedahmed epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT alnuaimiahmedsameer epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT aqotbahamdaabdulla epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT nasrallahgheyathk epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT althaniasmaaa epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT yassinehadim epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT zainelabduljaleelabdullatif epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT khudadadhanan epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT marjitamara epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT veettilshajithathekke epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT aljighefeehadeelt epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT younessalma epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT shurrabfarah epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT alsadeqduaaw epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT alfehaidialanoudsaleh epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT yfakhrooameenaibrahim epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT almesaifrimeshalabdulla epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT almujallihanan epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT alabdullasamyaahmad epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT alkuwarimohamedghaith epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT azadfarukmohammed epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT almalkibadriaalimohamed epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove AT abdulmalikmariamali epidemiologyofsarscov2inqatarsprimarycarepopulationaged10yearsandabove |